D
Apogee Therapeutics, Inc. APGE
$39.94 $1.614.20%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -67.22M -49.02M -33.82M -32.09M -31.74M
Total Depreciation and Amortization 76.00K 48.00K 36.00K 29.00K --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 5.38M 2.72M 2.94M 1.74M -541.00K
Change in Net Operating Assets -5.96M 3.73M 1.54M -1.31M 2.52M
Cash from Operations -67.71M -42.52M -29.30M -31.64M -29.75M
Capital Expenditure 1.00K -751.00K -51.00K -351.00K -167.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 46.37M -145.63M -148.66M -51.39M -39.53M
Cash from Investing 46.37M -146.38M -148.71M -51.74M -39.69M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 44.36M -- 32.90M 450.52M --
Repurchase of Common Stock -- -32.66M -- -- -213.00K
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- 33.05M -33.05M -- --
Cash from Financing 44.36M 383.00K -150.00K 450.52M -213.00K
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 23.01M -188.52M -178.16M 367.14M -69.66M
Weiss Ratings